Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mika Nakazawa is active.

Publication


Featured researches published by Mika Nakazawa.


Epilepsy & Behavior | 2013

Attitude toward epilepsy after media coverage of car accidents related to persons with epilepsy in Japan

Akihisa Okumura; Mika Nakazawa; Shinpei Abe; Toshiaki Shimizu

We compared the familiarity with and attitude toward epilepsy among nonmedical students before and after media coverage on car accidents related to persons with epilepsy in Japan. We have annually conducted a questionnaire survey on attitude toward epilepsy since 2008. We divided students into two groups: pre-accident era (years 2008-2010) and post-accident era (years 2011-2012). The rate of students who have read or heard about epilepsy was significantly higher in the post-accident era. Students in the post-accident era answered more frequently that they do not oppose the idea of their kids playing or attending school with children with epilepsy, they think that people with epilepsy should be hired in the same way as other people, and they do not oppose the idea of their children one day marrying a person with epilepsy. The results of our study show that media coverage of car accidents related to persons with epilepsy positively affected familiarity with and attitude toward epilepsy.


Brain & Development | 2013

Oral mexiletine for lidocaine-responsive neonatal epilepsy

Mika Nakazawa; Akihisa Okumura; Shinichi Niijima; Shintaro Yamashita; Kuriko Shimono; Shinichi Hirose; Toshiaki Shimizu

We report a patient with lidocaine-responsive neonatal epilepsy treated successfully with oral mexiletine. The patient was a male neonate who had seizures since 2days of age. While his seizures were refractory to phenobarbital, lamotrigine, vitamin B6, and midazolam, they were controlled by continuous lidocaine infusion. Oral mexiletine at serum levels of 0.2-0.4μg/ml was used successfully for long-term treatment of his seizures. No delay in psychomotor development was observed at the last follow-up at 20months of age. No mutation was identified in any of four genes: SCN1A, SCN1B, KCNQ2, and KCNQ3. Our patient demonstrates that oral mexiletine can be useful for long-term treatment of patients with lidocaine-responsive epilepsy.


Brain & Development | 2015

Efficacy and safety of fosphenytoin for acute encephalopathy in children

Mika Nakazawa; Manami Akasaka; Takeshi Hasegawa; Tomonori Suzuki; Taiki Shima; Jun-ichi Takanashi; Atsuko Yamamoto; Yuuki Ishidou; Kenjiro Kikuchi; Shinichi Niijima; Toshiaki Shimizu; Akihisa Okumura

PURPOSE To evaluate the efficacy and safety of fosphenytoin (fPHT) for the treatment of seizures in children with acute encephalopathy. METHODS Using responses from physicians on the Annual Zao Conference on Pediatric Neurology mailing list we chose patients who met the following criteria: clinical diagnosis of acute encephalopathy and use of intravenous fPHT for the treatment of seizures. We divided the patients into two groups: acute encephalopathy with biphasic seizures and late reduced diffusion (AESD) and other encephalopathies. The efficacy of fPHT was considered effective when a cessation of seizures was achieved. RESULTS Data of 38 children were obtained (median age, 27 months). Eighteen children were categorized into the AESD group and 20 into the other encephalopathies group. fPHT was administered in 48 clinical events. The median loading dose of fPHT was 22.5 mg/kg and was effective in 34 of 48 (71%) events. The rate of events in which fPHT was effective did not differ according to the presence or absence of prior antiepileptic treatment, subtype of acute encephalopathy, or the type of seizures. One patient experienced apnea and oral dyskinesia as adverse effects of fPHT, whereas arrhythmia, hypotension, obvious reduction of consciousness, local irritation, phlebitis and purple grove syndrome were not observed in any patient. CONCLUSION fPHT is effective and well tolerated among children with acute encephalopathy.


Brain & Development | 2015

Efficacy and safety of fosphenytoin for benign convulsions with mild gastroenteritis

Mika Nakazawa; Soichiro Toda; Shinpei Abe; Mitsuru Ikeno; Ayuko Igarashi; Eri Nakahara; Shintaro Yamashita; Shinichi Niijima; Toshiaki Shimizu; Akihisa Okumura

OBJECTIVE To clarify the efficacy and safety of fosphenytoin for seizures in children with benign convulsions and mild gastroenteritis. METHODS Using the mailing list of the Annual Zao Conference on Pediatric Neurology, we recruited patients who met the following criteria: (1) clinical diagnosis of benign convulsions with mild gastroenteritis and (2) treatment with intravenous fosphenytoin. Benign convulsions with mild gastroenteritis were defined as a condition of (a) seizures associated with gastroenteritis without electrolyte imbalance, hypoglycemia, or dehydration in patients (b) between 6 months and 3 years of age with (c) no preexisting neurological disorders, (d) no impaired consciousness, and (e) a body temperature less than 38.0 °C before and after the seizures. The efficacy of fosphenytoin was categorized as effective when cessation of seizures was achieved. RESULTS Data from 16 child patients were obtained (median age, 20 months). Seizures were completely controlled after the initial dose of fosphenytoin in 14 of 16 patients. The median loading dose of fosphenytoin was 22.5 mg/kg. In 10 patients, fosphenytoin was administered after other antiepileptic drugs such as diazepam and midazolam were used. Adverse effects of fosphenytoin, excessive sedation, or intravenous fluid incompatibility were not observed in any patients. CONCLUSION Fosphenytoin is effective and well tolerated among children with benign convulsions with mild gastroenteritis.


Brain & Development | 2015

Anti-aquaporin 4 antibody-positive acute disseminated encephalomyelitis

Akihisa Okumura; Mika Nakazawa; Ayuko Igarashi; Shinpei Abe; Mitsuru Ikeno; Eri Nakahara; Yuichiro Yamashiro; Toshiaki Shimizu; Toshiyuki Takahashi

OBJECTIVE To describe the clinical and neuroimaging features of a young female patient with acute disseminated encephalomyelitis associated with anti-aquaporin-4 antibodies. METHODS The patient had mild encephalopathy 14 days after influenza vaccination. Cerebrospinal fluid analysis revealed an increased cell count and a marked increase in myelin basic protein. Magnetic resonance imaging (MRI) demonstrated multiple lesions in the juxtacortical white matter. The patient was diagnosed with acute disseminated encephalomyelitis and treated with methylprednisolone pulse therapy. She recovered in 1 month. However, right retrobulbar optic neuritis appeared 2 months after discharge, and serum anti-aquaporin 4 antibodies were measured with a cell-based assay. RESULTS Anti-aquaporin 4 antibodies were present in the patients serum. She was treated with a prolonged course of oral prednisolone. The patient was negative for serum anti-aquaporin 4 antibodies 8 months after the second clinical event, and prednisolone was discontinued 13 months after the second clinical event. Serum anti-aquaporin 4 antibodies remained negative 4 months after the discontinuation of prednisolone. There was no evidence of relapse at 9 months after discontinuation of steroids. CONCLUSIONS This case will expand the spectrum of anti-aquaporin-4 antibody-related central nervous system disorders. The measurement of anti-aquaporin 4 antibody may be considered in patients with a clinical diagnosis of acute disseminated encephalomyelitis and a second clinical event within a short interval.


Pediatrics International | 2014

Is attitude toward epilepsy and driving affected by media coverage

Akihisa Okumura; Shinpei Abe; Mika Nakazawa; Toshiaki Shimizu

The media have recently reported on car accidents related to persons with epilepsy in Japan. We were concerned that sensational media coverage may worsen the attitude toward epilepsy among non‐medical persons. We carried out a questionnaire survey among non‐medical students in order to evaluate the effects of media on the attitude toward epilepsy and the holding of a driving license in persons with epilepsy.


Epilepsy & Behavior | 2015

Sustained improvement of attitudes about epilepsy following a reduction in media coverage of car accidents involving persons with epilepsy

Akihisa Okumura; Mika Nakazawa; Shinpei Abe; Mitsuru Ikeno; Ayuko Igarashi; Toshiaki Shimizu

To evaluate changes in the attitudes of nonmedical students about epilepsy, the present study compared the results of a questionnaire that was completed in three different time periods: before media coverage of car accidents associated with epilepsy, during a period of abundant media coverage about epilepsy-related accidents, and after media coverage of epilepsy-related accidents. The nonmedical students who completed the questionnaire were divided into three groups: Years 08-10 (preaccident era), Years 11-12 (media coverage era), and Years 13-14 (postmedia coverage era). The rates of students who had read or heard about epilepsy and of students who did not think that epilepsy was a mental disorder increased annually throughout the study period. There was an improvement in attitudes about epilepsy after the media coverage era, and this change was not altered even after a decrease in the media coverage of epilepsy-related car accidents. Additionally, the rate of positive answers did not differ between Years 11-12 and Years 13-14. These findings demonstrate that the familiarity with and improved attitudes about epilepsy were sustained even after the media coverage of car accidents involving persons with epilepsy had decreased.


Pediatrics International | 2017

Attitudes toward driver's licenses for people with epilepsy: 2012 versus 2014.

Akihisa Okumura; Shinpei Abe; Mika Nakazawa; Mitsuru Ikeno; Ayuko Igarashi; Michihiko Takasu; Toshiaki Shimizu

We compared knowledge about and attitudes toward epilepsy and the issuing of drivers licenses to people with epilepsy among non‐medical students before and after media controversies.


Brain & Development | 2016

Efficacy and tolerability of high-dose phenobarbital in children with focal seizures

Akihisa Okumura; Eri Nakahara; Mitsuru Ikeno; Shinpei Abe; Ayuko Igarashi; Mika Nakazawa; Michihiko Takasu; Toshiaki Shimizu

OBJECTIVE We retrospectively reviewed the outcomes of children with focal epilepsy treated with oral high-dose phenobarbital. METHODS We reviewed data on children (aged<15 years) with focal seizures treated with high-dose phenobarbital (>5 mg/kg/day to maintain a target serum level >40 μg/mL) for at least 6 months. Seizure frequency was evaluated after phenobarbital titration, and 1 and 2 years after high-dose phenobarbital treatment commenced. Treatment was judged effective when seizure frequencies fell by ⩾75%. RESULTS Seven boys and eight girls were treated. The median age at commencement of high-dose phenobarbital therapy was 30 months. The maximal serum phenobarbital level ranged from 36.5 to 62.9 μg/mL. High-dose PB was effective in seven. In two patients, treatment was transiently effective, but seizure frequency later returned to the baseline. High-dose PB was ineffective in six. No significant association between effectiveness and any clinical variable was evident. Drowsiness was recorded in nine patients, but no patient developed a behavioral problem or hypersensitivity. CONCLUSION Oral high-dose phenobarbital was effective in 7 of 15 patients with focal epilepsy and well tolerated. High-dose PB may be useful when surgical treatment is difficult.


Epilepsy & Behavior | 2016

Worsening of attitudes toward epilepsy following less influential media coverage of epilepsy-related car accidents: an infodemiological approach

Akihisa Okumura; Shinpei Abe; Hirokazu Kurahashi; Michihiko Takasu; Mitsuru Ikeno; Mika Nakazawa; Ayuko Igarashi; Toshiaki Shimizu

To evaluate changes in the attitudes of nonmedical university students toward epilepsy in 2015, the present study compared the results of questionnaire surveys from four different time periods: before media coverage of epilepsy-related car accidents (2008-2010), during a period of abundant media coverage (2011-2012), after media coverage (2013-2014), and after novel media coverage (2015). The nonmedical students that completed the questionnaire were divided into four groups: 2008-2010, 2011-2012, 2013-2014, and 2015. The rates of students that had read or heard about epilepsy decreased significantly in 2015 compared with those in 2013-2014. Attitudes toward epilepsy had also worsened in 2015. The rates of students that would not oppose their children playing with or attending school alongside children with epilepsy and those who thought that people with epilepsy should be hired in the same way as other people had decreased significantly in 2015 compared with those in 2011-2012 and 2013-2014. Analyses of information-seeking behavior on the Internet showed that the increase in Google search volume and Wikipedia page views was much less in 2015 than in 2011 and 2012. These findings suggest that familiarity with epilepsy had worsened even after media coverage of novel epilepsy-related car accidents. This suggests that media coverage in 2015 was less influential than that in 2011 and 2012.

Collaboration


Dive into the Mika Nakazawa's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge